UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain

European journal of clinical microbiology & infectious diseases, 2020-04, Vol.39 (4), p.703-710

2020

Volltextzugriff (PDF)

Short-term Neuropsychiatric and Body Weight Changes in Patients Switching From EVG/Cobi/FTC/TAF to BIC/FTC/TAF (PreEC/RIS69)

Current HIV research, 2022-01, Vol.20 (3), p.251-254

2022

Volltextzugriff (PDF)

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

Infectious diseases and therapy, 2024-03, Vol.13 (3), p.609-617

2024

Volltextzugriff (PDF)

Vaccination coverage for people living with HIV: a key intervention that should be improved

Enfermedades infecciosas y microbiologia clinica (English ed.), 2023-03, Vol.41 (3), p.141-143

2023

Volltextzugriff (PDF)

Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain

Vaccines (Basel), 2023-12, Vol.12 (1), p.44

2023

Volltextzugriff (PDF)

SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV

Microorganisms (Basel), 2022-08, Vol.10 (8), p.1666

2022

Volltextzugriff (PDF)

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

PloS one, 2017-02, Vol.12 (2), p.e0172184-e0172184

2017

Volltextzugriff (PDF)

Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV

Expert review of anti-infective therapy, 2017-03, Vol.15 (3), p.195-209

2017

Volltextzugriff (PDF)

Vaccination coverage for people living with HIV: a key intervention that should be improved

Enfermedades infecciosas y microbiologia clinica (English ed.), 2023-03, Vol.41 (3), p.141-143

2023

Volltextzugriff (PDF)

Lack of benefit with omega-3 fatty acid supplementation in HIV patients: A randomized pilot study

HIV research & clinical practice, 2019-05, Vol.20 (3), p.99-105

2019

Volltextzugriff (PDF)

Clinical considerations when switching antiretroviral therapy

Expert review of clinical pharmacology, 2024-07, Vol.17 (7), p.565-577

2024

Volltextzugriff (PDF)

Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response

Clinical infectious diseases, 2021-03, Vol.72 (5), p.e96-e102

2021

Volltextzugriff (PDF)

Dual antiretroviral therapy: finding a place in the battle

The lancet HIV, 2016-08, Vol.3 (8), p.e335-e336

2016

Volltextzugriff (PDF)

Changes in Body Fat Distribution in Antiretroviral-Naive HIV-Positive Individuals Initiating Current ART Regimens

The journal of clinical endocrinology and metabolism, 2019-03, Vol.104 (3), p.900-905

2019

Volltextzugriff (PDF)

Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56)

The Journal of infectious diseases, 2020-04, Vol.221 (9), p.1425-1428

2020

Volltextzugriff (PDF)

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

The Journal of infectious diseases, 2023-10, Vol.228 (7), p.919-925

2023

Volltextzugriff (PDF)

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Journal of pharmaceutical and biomedical analysis, 2022-10, Vol.220, p.115010-115010, Article 115010

2022

Volltextzugriff (PDF)

Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome

AIDS (London), 2020-11, Vol.34 (14), p.2097-2101

2020

Volltextzugriff (PDF)

Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV

Clinica chimica acta, 2024-01, Vol.552, p.117678-117678, Article 117678

2024

Volltextzugriff (PDF)

Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide

Clinical infectious diseases, 2022-11, Vol.75 (11), p.2012-2015

2022

Volltextzugriff (PDF)

Total and Unbound Doravirine Concentrations and Viral Suppression in CSF

Clinical infectious diseases, 2022-05, Vol.74 (10), p.1855-1858

2022

Volltextzugriff (PDF)

Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease

Journal of antimicrobial chemotherapy, 2022-06, Vol.77 (7), p.1989-1991

2022

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(105)
Berichte
(2)

Sprache

Englisch
(101)
Spanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain

Short-term Neuropsychiatric and Body Weight Changes in Patients Switching From EVG/Cobi/FTC/TAF to BIC/FTC/TAF (PreEC/RIS69)

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

Vaccination coverage for people living with HIV: a key intervention that should be improved

Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain

SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV

Vaccination coverage for people living with HIV: a key intervention that should be improved

Lack of benefit with omega-3 fatty acid supplementation in HIV patients: A randomized pilot study

Clinical considerations when switching antiretroviral therapy

Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response

Dual antiretroviral therapy: finding a place in the battle

Changes in Body Fat Distribution in Antiretroviral-Naive HIV-Positive Individuals Initiating Current ART Regimens

Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56)

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome

Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV

Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide

No impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response

Total and Unbound Doravirine Concentrations and Viral Suppression in CSF

Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease

Suchergebnisse filtern